The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Suicide associated with alfa-interferon therapy for chronic viral hepatitis
Abstract
We report on two attempted suicides and one successful suicide during or shortly after alfa-interferon therapy for chronic viral hepatitis. While on therapy, all three patients developed a psychiatric disorder leading to their suicidal behavior. In a survey of 15 European hospitals, three cases of attempted and two of successful suicide during alfa-interferon therapy for chronic viral hepatitis, were additionally reported. None of the patients had a psychiatric history. Alfa-interferon is known to lead to neuropsychiatric symptoms, and our observations strongly suggest that these mental disorders could lead to suicidal behavior. Therefore it is important that physicians, patients and their families are informed about the potential risk of the emotional and psychiatric disturbances that can occur during alfa-interferon therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specific symptoms induced by IFNα administration include anxiety, pain, depressed mood, anhedonia, fatigue, cognitive impairment, sleep disturbance, anger, hostility, loss of appetite, and suicidal ideation”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as Janssen, Brouwer, van der Mast, & Schalm, 1994
In the citing paper
“Studies of patients receiving this treatment have shown that IFN-α can induce symptoms of depressed mood, fatigue, sleep disturbance, loss of appetite, pain, anxiety, anhedonia, anger, hostility, cognitive impairment, and suicidal ideation (Capuron et al., 2002; Janssen et al., 1994; Lotrich et al., 2007).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as Janssen et al., 1994
Citations
Cites
1 retracted
Suicide in 24 European countries, 1972-1984.
Diekstra, R. F. W., & Kerkhof, A. J. F. M. (1988) · PubMed · Cited by 4
RetractedPsychiatric Complications of Long-term Interferon Alfa Therapy
Renault, P. F. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370090055011 · Cited by 413
Smith, E. M., & Blalock, J. E. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.12.7530 · Cited by 359
INTERFERONS AS MEDIATORS OF PSYCHIATRIC MORBIDITY
Mcdonald, E. M., Mann, A. H., & Thomas, H. C. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91319-5 · Cited by 248
Side Effects of Alpha Interferon
Renault, P., & Hoofnagle, J. H. (1989) · Seminars in Liver Disease · doi:10.1055/s-2008-1040523 · Cited by 223
Interferon enhances the excitability of cultured neurones
Calvet, M.-C., & Gresser, I. (1979) · Nature · doi:10.1038/278558a0 · Cited by 129
Suicide and its prevention : the role of attitude and imitation
Diekstra, R. F. W. (1988) · Medical Entomology and Zoology · Cited by 66
Electroencephalographic Abnormalities in Interferon Encephalopathy: A Preliminary Report
Suter, C. C., Westmoreland, B. F., Sharbrough, F. W., & Hermann, R. C. (1984) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65620-1 · Cited by 61
Seizures associated with low-dose α-interferon
Janssen, H. L. A., Berk, L., Vermeulen, M., & Schalm, S. W. (1990) · The Lancet · doi:10.1016/0140-6736(90)93356-t · Cited by 49
Self-citationDerrick, E. H. (1941) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1941.tb108512.x · Cited by 32
Research works printed but not linked: 1
- Diekstra, 1988, Suicide in 24 Europese landen, 1972–1984, Ned Tijdschr Geneeskd, 132, 67
Cited by
Sorted by citations
Items 201–230 of 230
Kageyama, K., Sato, M., Ito, S., Ino, Y., Nakao, S., Bunchuailua, W., Rungpragayphan, S., Krichanchai, S., Iguchi, K., Ishiguro, M., et al. (2026) · Psychiatry Research Communications · doi:10.1016/j.psycom.2026.100250 · Cited by 1
Shiner, B. R., Watts, B. V., Rozema, L. R., & Gradus, J. L. (2025) · Clinical Therapeutics · doi:10.1016/j.clinthera.2025.09.008 · Cited by 1
Hepatitis C: Who Should You Treat and How?
Tapias, J. M. S., & Rodés, J. (2002) · Blood Purification · doi:10.1159/000046996 · Cited by 1
Ducasse, D., Girod, C., & Courtet, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-26282-6_10 · Cited by 1
Delicate Situation of Bipolar Disorder and Interferon Therapy
Aarab, C., Aalouane, R., Boujraf, S., & Rammouz, I. (2018) · Journal of Neurosciences in Rural Practice · doi:10.4103/jnrp.jnrp_179_17 · Cited by 1
Givon, L. (2019) · Current clinical psychiatry · doi:10.1007/978-3-319-23961-3_6 · Cited by 1
Inflammatory Bowel Disease and Liver Disease
Hommel, K. A. (2007) · Wiley eBooks · doi:10.1002/9781118269657.ch14 · Cited by 1
Heinze, S. (2009) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-5622 · Cited by 1
Vigani, A. G. (2007) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702007000700020 · Cited by 1
Fatigue und Lebensqualität bei Patienten mit chronischer Hepatitis C
Güner-Capraz, N., & Matern, S. (2005) · RWTH Publications (RWTH Aachen) · Cited by 1
Living with Hepatitis C : a psychosocial exploration of hepatitis C infection and its treatment
Hopwood, M. (2007) · doi:10.26481/dis.20070928mh · Cited by 1
Interferon Treatment of Viral Hepatitis
Bailly, F., & TREPO, C. G. (1997) · BioDrugs · doi:10.2165/00063030-199708010-00003 · Cited by 1
Lebensqualität bei Melanom- Patienten unter adjuvanter Interferon- alpha 2a- Therapie
Rötzer, S. (2008) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-17787
Bezemer, G. (2012) · RePub (Erasmus University Rotterdam)
Anty, R., Vanbiervliet, G., Benzaken, S., Rampal, P., & Tran, A. (2004) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(04)94923-8
Therapie der Hepatitis-C-Infektion
Wedemeyer, H. H., Manns, M. P., & Cornberg, M. (2001) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s001030170003
Interferón y depresión. A propósito de un caso
Arroyoa, I. L., & Carriedo, E. R. (2004) · Atención Primaria · doi:10.1016/s0212-6567(04)78931-3
Mooney, S. (2005) · ThinkTech (Texas Tech University)
complicationsviral hepatitis C: efficacy, side effects, and
Manns, M. P., Wedemeyer, H. H., & Cornberg, M. (2007)
Herrine, S. K., Rossi, S., & Navarro, V. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50039-1
(2006) · Elsevier eBooks · doi:10.1016/b0-44-451005-2/00862-7
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.00900-8
&NA; (1994) · Reactions Weekly · doi:10.2165/00128415-199405250-00027
ANTIVIRAL DRUGS, INCLUDING IMMUNOGLOBULINS AND INTERFERONS
(2010) · Elsevier eBooks · doi:10.1016/b978-0-444-53272-5.50006-6
CYTOKINES AND CYTOKINE MODULATORS
(2010) · Elsevier eBooks · doi:10.1016/b978-0-444-53267-1.50006-x
Treatment of chronic hepatitis B: options, monitoring, special cases and adverse effects
Litwin, M., Mikosińska, A., Parys, J., Kałuziak, P., Witek, A., Kaźmierczak, M., Jesionek, S., Jajczak, M., & Mossakowski, M. (2025) · Journal of Education Health and Sport · doi:10.12775/jehs.2025.77.57419
Simonetti, G. <. (2015) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/6755
Long-term effects of imatinib on cognition in chronic myeloid leukaemia
Shiell, K. (2009) · Victoria University Research Repository (Victoria University)
Metadata
- Authors
- Janssen, H. L. A., Brouwer, J. T., van der Mast, R. C., & Schalm, S. W.
- Affiliations
- Academisch Ziekenhuis Rotterdam (NL)
- Corresponding author
- Schalm, Solko W.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 1994-01
- Volume
- 21
- Issue
- 2
- Pages
- 241-243
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2158811343
- Cited by
- 229
- References
- 11
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 4 · 2018: 2 · 2017: 4 · 2016: 5 · 2015: 10 · 2014: 6 · 2013: 5 · 2012: 5
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- suicide, interferon-alpha, chronic viral hepatitis, psychiatric adverse effects, neuropsychiatric symptoms, suicidal behavior, drug-induced psychiatric disorders, hepatitis C treatment
- MeSH terms
- Adult, Chronic Disease, Female, Hepatitis, Viral, Human, Humans, Male, Middle Aged, Suicide, Attempted, Interferon-alpha
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
